Gilead Sciences Contributes Additional $85 Million to Its Foundation to Advance Health Equity – Gilead Sciences

Share Article

July 20, 2022

FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) today announced an $85 million contribution to the Gilead Foundation to further the company’s vision of creating a healthier world for all people. This donation builds on the endowment Gilead announced last year to recapitalize the Gilead Foundation, with a new vision and mission to create impact in the community and society by encouraging a culture of giving, engaging in local communities and exploring innovative approaches to complex social issues.
“Our additional contribution to the Gilead Foundation demonstrates our continued commitment to supporting communities and advancing health equity,” said Andrew Dickinson, Chief Financial Officer, Gilead Sciences and Director, Gilead Foundation. “We are proud to dedicate our philanthropic resources in this way because we believe a more just society is a healthier one.”
One of the Gilead Foundation’s giving pillars is the innovative Creating Possible Fund, which will announce its inaugural cohort of grants later this fall with the theme of Advancing Health Prosperity Through Education Equity, which is focused on addressing systemic barriers to equitable education for underserved and excluded adolescents. Research is clear that closing gaps in educational outcomes is necessary to promote health equity for underserved and excluded communities. The Gilead Foundation is committed to supporting efforts to ensure that all people have full and equal access to educational and economic opportunities that enable them to lead healthy lives.
The Gilead Foundation also supports charitable programs in local communities where Gilead employees live and work. Near its headquarters in San Mateo County, the Gilead Foundation recently provided the local school district with funding for STEM programming, as well as support for a mobile education and health program for underserved farmworker communities.
“Gilead is a pioneer in corporate stewardship and investing in the local community,” said Annie Tsai, Board President, San Mateo-Foster City Education Foundation. “It has been an honor to collaborate with the Gilead Foundation on expanding opportunities for STEM learning at SMFCSD, San Mateo County’s largest public school district. As we live in an area with one of the largest wealth gaps in the country, achieving educational equity for all of our community’s children is our priority and we are thrilled that Gilead has chosen to invest their resources into this important initiative.”
The Gilead Foundation also encourages a culture of employee giving through its donation matching program for employees, Giving Together.
“We have seen how generous our employees are – a recent matching donation program for employees in support of humanitarian relief efforts in Ukraine has raised more than $750,000 to date, in addition to the $3 million donated by the Gilead Foundation,” said Jyoti Mehra, Executive Vice President, Human Resources, Gilead Sciences and Director, Gilead Foundation. “Gilead’s employees work hard to bring new possibilities to millions of patients around the world, and they are equally committed to creating new possibilities for health prosperity for all people through the Gilead Foundation.”
The Gilead Foundation is one example of the philanthropic reach of the company, whose global corporate giving is recognized as the number one funder in HIV: https://www.gilead.com/news-and-press/press-room/press-releases/2022/5/gilead-reaches-number-one-spot-as-top-overall-philanthropic-funder-of-hivrelated-programs-according-to-funders-concerned-about-aids-report.
For more information on the Gilead Foundation, visit: https://www.gilead.com/purpose/giving/gilead-foundation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead has promoted equity, particularly healthcare equity, since the company brought its first therapies to the market. Through global partnerships, Gilead’s medicines today reach millions of people in low- and middle-income countries around the world.
Gilead and the Gilead logo are trademarks of Gilead Sciences, Inc., or its related companies.
For more information about Gilead, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@Gilead Sciences) or call Gilead Public Affairs at 1-800- GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220719006080/en/
Jacquie Ross, CFA, Investors
(650) 358-1054
Hayley Home, Media
(916) 402-2864
Source: Gilead Sciences, Inc.
© 1996-2022 Gilead Sciences, Inc. All rights reserved.
AREAS OF INTEREST
INFORMATION
LEGAL
FOLLOW US
Intersititial body copy
Some content on this site is not intended for people outside the United States.

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness